Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma
Authors
Keywords
-
Journal
PLoS One
Volume 12, Issue 4, Pages e0174835
Publisher
Public Library of Science (PLoS)
Online
2017-04-04
DOI
10.1371/journal.pone.0174835
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
- (2015) Shicong Zhu et al. Oncotarget
- Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance
- (2015) Oncotarget
- INCB16562, a JAK1/2 Selective Inhibitor, Is Efficacious against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support
- (2015) Jun Li et al. NEOPLASIA
- Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells
- (2014) Sung-Moo Kim et al. CANCER LETTERS
- Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases
- (2013) Jong Hyun Lee et al. CANCER LETTERS
- Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies
- (2013) Tariq I. Mughal et al. LEUKEMIA & LYMPHOMA
- β-caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase
- (2013) Chulwon Kim et al. MOLECULAR CARCINOGENESIS
- An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma
- (2012) Huiqiong Lin et al. EXPERIMENTAL CELL RESEARCH
- Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
- (2012) Pasquale Sansone et al. JOURNAL OF CLINICAL ONCOLOGY
- JAK/STAT signaling in hematological malignancies
- (2012) W Vainchenker et al. ONCOGENE
- Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular Carcinogenesis
- (2011) Emilie A. Bard-Chapeau et al. CANCER CELL
- Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells
- (2010) Wei-Lun Huang et al. Molecular Cancer
- DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance
- (2009) Carmen Stanganelli et al. ANNALS OF HEMATOLOGY
- 1 Integrin Adhesion Enhances IL-6-Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation
- (2009) K. H. Shain et al. CANCER RESEARCH
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started